Abacavir, an FDA‐applied anti‐retroviral drug, is identified to prevent excessive gliosis and neuron loss in both glia‐neuron co‐cultures and PD mouse models by rejuvenating FGF13 signaling. Here, FGF13 is linked to Parkinson disease.